SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$4,000
-96.3%
16,733
-78.6%
0.00%
-100.0%
Q1 2022$108,000
-9.2%
78,099
-20.4%
0.00%
-33.3%
Q4 2021$119,000
-62.3%
98,130
-18.7%
0.00%
-50.0%
Q3 2021$316,000
+109.3%
120,678
+324.7%
0.01%
+100.0%
Q2 2021$151,000
-12.7%
28,418
+72.2%
0.00%
-62.5%
Q2 2020$173,00016,5000.01%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vahanian & Associates Financial Planning Inc. 181,384$54,0000.23%
Samsara BioCapital, LLC 601,162$180,0000.05%
Board of Trustees of The Leland Stanford Junior University 688,701$207,0000.01%
Matisse Capital 36,800$11,0000.01%
Knights of Columbus Asset Advisors LLC 120,841$36,0000.00%
Covestor Ltd 11,972$4,0000.00%
Ergoteles LLC 219,461$66,0000.00%
Virtu Financial LLC 74,636$22,0000.00%
IPG Investment Advisors LLC 14,300$4,0000.00%
Aquatic Capital Management LLC 13,200$4,0000.00%
View complete list of KALA PHARMACEUTICALS INC shareholders